Sale!

Immunohistochemistry HHV-8 Test

610 د.إ

-10%

The Immunohistochemistry HHV-8 Test is a specialized diagnostic procedure designed to detect the presence of Human Herpesvirus 8 (HHV-8), also known as Kaposi’s sarcoma-associated herpesvirus (KSHV). This virus is associated with several types of cancers, including Kaposi’s sarcoma, primary effusion lymphoma, and some forms of multicentric Castleman’s disease. The test employs immunohistochemistry (IHC) techniques, which involve the use of specific antibodies to identify HHV-8 antigens within tissue samples. This method provides a visual confirmation of the virus in the cells, making it a valuable tool for accurate diagnosis and guiding treatment decisions.

The cost of the Immunohistochemistry HHV-8 Test at DNA Labs UAE is 610 AED. DNA Labs UAE is a reputable facility known for its state-of-the-art equipment and highly trained staff, ensuring reliable and precise test results. By opting for this test at DNA Labs UAE, patients and healthcare providers can expect a high level of diagnostic accuracy, which is crucial for the effective management and treatment of conditions associated with HHV-8.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY HHV-8 Test

At DNA Labs UAE, we offer the IMMUNOHISTOCHEMISTRY HHV-8 test for the detection of Human Herpesvirus 8 (HHV-8) in tissue samples. This diagnostic tool is commonly used in the diagnosis of Kaposi’s sarcoma, a type of cancer that primarily affects the skin and mucous membranes.

Test Components and Price

The IMMUNOHISTOCHEMISTRY HHV-8 test is priced at 610.0 AED. The test components include:

  • Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
  • Report Delivery: Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex: 7 days
  • Method: Immunohistochemistry
  • Test Type: Cancer
  • Doctor: Oncologist, Pathologist
  • Test Department: HISTOLOGY
  • Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Test Details

The immunohistochemistry HHV-8 test is performed by staining tissue sections with specific antibodies that target HHV-8 antigens. These antibodies bind to the viral proteins present in the tissue sample, allowing for their visualization under a microscope. The presence of HHV-8 antigens indicates an active infection or viral presence within the tissue.

This test is commonly used in the diagnosis of Kaposi’s sarcoma, as the presence of HHV-8 is a key factor in confirming the disease. It can also be used to differentiate Kaposi’s sarcoma from other similar conditions, such as vascular tumors or inflammatory lesions.

The immunohistochemistry HHV-8 test is typically performed on biopsy samples obtained from the affected area. The tissue is fixed, embedded in paraffin, and cut into thin sections. These sections are then stained with the HHV-8-specific antibodies and examined under a microscope by a pathologist.

The test results are interpreted based on the presence or absence of HHV-8 antigen staining in the tissue. Positive staining indicates the presence of HHV-8 and supports the diagnosis of Kaposi’s sarcoma, while negative staining suggests the absence of HHV-8 or a low viral load.

It is important to note that while the immunohistochemistry HHV-8 test is a valuable tool in the diagnosis of Kaposi’s sarcoma, it is not a standalone test. Clinical history, physical examination, and other laboratory tests may also be used to confirm the diagnosis and guide treatment decisions.

Test Name IMMUNOHISTOCHEMISTRY HHV-8 Test
Components
Price 610.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist, Pathologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The immunohistochemistry HHV-8 test is a diagnostic tool used to detect the presence of Human Herpesvirus 8 (HHV-8) in tissue samples. HHV-8 is a virus that has been associated with the development of Kaposi’s sarcoma, a type of cancer that primarily affects the skin and mucous membranes.

The immunohistochemistry test involves staining tissue sections with specific antibodies that target HHV-8 antigens. These antibodies bind to the viral proteins present in the tissue sample, allowing for their visualization under a microscope. The presence of HHV-8 antigens indicates an active infection or viral presence within the tissue.

This test is commonly used in the diagnosis of Kaposi’s sarcoma, as the presence of HHV-8 is a key factor in confirming the disease. It can also be used to differentiate Kaposi’s sarcoma from other similar conditions, such as vascular tumors or inflammatory lesions.

The immunohistochemistry HHV-8 test is typically performed on biopsy samples obtained from the affected area. The tissue is fixed, embedded in paraffin, and cut into thin sections. These sections are then stained with the HHV-8-specific antibodies and examined under a microscope by a pathologist.

The test results are interpreted based on the presence or absence of HHV-8 antigen staining in the tissue. Positive staining indicates the presence of HHV-8 and supports the diagnosis of Kaposi’s sarcoma, while negative staining suggests the absence of HHV-8 or a low viral load.

It is important to note that while the immunohistochemistry HHV-8 test is a valuable tool in the diagnosis of Kaposi’s sarcoma, it is not a standalone test. Clinical history, physical examination, and other laboratory tests may also be used to confirm the diagnosis and guide treatment decisions.